EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cardiovascular Risk Assessment in Rheumatoid Arthritis: Accelerated Atherosclerosis, New Biomarkers, and the Effects of Biological Therapy

Diana Popescu, Elena Rezus iD, Minerva Codruta Badescu iD, Nicoleta Dima, Petronela Nicoleta Seritean Isac, Ioan-Teodor Dragoi, Ciprian Rezus iD

Life · 23.01.2023 · 13 (2) · 319

DOI: 10.3390/life13020319 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Life, online erschienen am 23.01.2023. Verfasst von Diana Popescu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 16 University Street, 700115 Iasi, Romania. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 224 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rheumatoid arthritis (RA), one of the most common of the chronic inflammatory autoimmune diseases (CIADs), is recognized as an independent cardiovascular risk factor. Traditional risk factors such as smoking, arterial hypertension, dyslipidemia, insulin resistance, and obesity are frequently found in RA. Given the increased risk of mortality and morbidity associated with cardiovascular disease (CVD) in RA patients, screening for risk factors is important. Moreover, there is a need to identify potential predictors of subclinical atherosclerosis. Recent studies have shown that markers such as serum homocysteine, asymmetric dimethylarginine, or carotid intima–media thickness (cIMT) are correlated with cardiovascular risk. Although RA presents a cardiovascular risk comparable to that of diabetes, it is not managed as well in terms of acute cardiovascular events. The introduction of biological therapy has opened new perspectives in the understanding of this pathology, confirming the involvement and importance of the inflammatory markers, cytokines, and the immune system. In addition to effects in inducing remission and slowing disease progression, most biologics have demonstrated efficacy in reducing the risk of major cardiovascular events. Some studies have also been conducted in patients without RA, with similar results. However, early detection of atherosclerosis and the use of targeted therapies are the cornerstone for reducing cardiovascular risk in RA patients.

Schlagwörter

Stichwörter der Autor:innen

atherosclerosisautoimmune diseasebiological therapycardiovascular riskinflammationrheumatoid arthritis

Autor:innen und Institutionen

  • Department of Internal Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 16 University Street, 700115 Iasi, Romania.
  • Internal Medicine Clinic, "Sf. Spiridon" County Clinical Emergency Hospital, 700111 Iasi, Romania.
  • Department of Rheumatology and Physiotherapy, "Grigore. T. Popa" University of Medicine and Pharmacy, 16 University Street, 700115 Iasi, Romania.
  • Rheumatology Clinic, Clinical Rehabilitation Hospital, 700661 Iasi, Romania.

ORCID-Profile: Elena Rezus, Minerva Codruta Badescu, Ciprian Rezus

Zitieren

APA

Popescu, D., Rezus, E., Badescu, M. C., Dima, N., Seritean Isac, P. N., Dragoi, I. T., & Rezus, C. (2023). Cardiovascular Risk Assessment in Rheumatoid Arthritis: Accelerated Atherosclerosis, New Biomarkers, and the Effects of Biological Therapy. Life, 13(2), 319. https://doi.org/10.3390/life13020319

Vancouver

Popescu D, Rezus E, Badescu MC, Dima N, Seritean Isac PN, Dragoi IT, et al. Cardiovascular Risk Assessment in Rheumatoid Arthritis: Accelerated Atherosclerosis, New Biomarkers, and the Effects of Biological Therapy. Life. 2023;13(2):319. doi:10.3390/life13020319

BibTeX
@article{Popescu2023,
  author = {Popescu, Diana and Rezus, Elena and Badescu, Minerva Codruta and Dima, Nicoleta and Seritean Isac, Petronela Nicoleta and Dragoi, Ioan-Teodor and Rezus, Ciprian},
  title = {Cardiovascular Risk Assessment in Rheumatoid Arthritis: Accelerated Atherosclerosis, New Biomarkers, and the Effects of Biological Therapy},
  journal = {Life},
  year = {2023},
  volume = {13},
  number = {2},
  pages = {319},
  doi = {10.3390/life13020319}
}
Kostenlos starten →